Aveanna Healthcare and DaVita are currently highlighted as potentially undervalued stocks based on key valuation metrics. Aveanna Healthcare holds a Zacks Rank #2 (Buy) and an A grade for Value, with a P/E ratio of 17.55 compared to its industry average of 17.67 and a P/S ratio of 0.73 versus the industry's 1.25. DaVita carries a Zacks Rank #1 (Strong Buy) and an A grade for Value, trading at a forward earnings multiple of 10.65 and a PEG ratio of 0.83, while its industry averages are 17.67 and 1.37 respectively. Both companies operate in the Medical - Outpatient and Home Healthcare industry, and their current valuation levels combined with positive earnings outlooks make them stand out among value stocks.
Aveanna Healthcare Holdings IncHighlighted as undervalued with strong value metrics and a Zacks Rank #2 (Buy), indicating positive analyst valuation.
DaVita HealthCare Partners IncHighlighted as undervalued with strong value metrics and a Zacks Rank #1 (Strong Buy), indicating positive analyst valuation.